{"id":"NCT01454531","sponsor":"ALK-Abell√≥ A/S","briefTitle":"An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy","officialTitle":"An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2011-06","primaryCompletion":"2012-03","completion":"2012-04","firstPosted":"2011-10-19","resultsPosted":"2015-03-06","lastUpdate":"2015-03-06"},"enrollment":199,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Allergic Rhinoconjunctivitis"],"interventions":[{"type":"DRUG","name":"AVANZ Phleum pratense","otherNames":[]}],"arms":[{"label":"AVANZ Phleum pratense","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the tolerability of AVANZ.","primaryOutcome":{"measure":"Frequency of Subjects With Adverse Drug Reactions","timeFrame":"6 weeks","effectByArm":[{"arm":"AVANZ Phleum Pratense","deltaMin":133,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":1},"locations":{"siteCount":20,"countries":["Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":192},"commonTop":["Local reactions","Urticaria","Rhinitis allergic","Hypersensitivity"]}}